Kodiak Sciences Inc (KOD) financial statements (2021 and earlier)

Company profile

Business Address 1200 PAGE MILL RD
PALO ALTO, CA 94304
State of Incorp. DE
Fiscal Year End December 31
SIC 2836 - Biological Products, Except Diagnostic Substances (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments96933688
Cash and cash equivalents94421288
Short-term investments25125 
Other undisclosed current assets332
Total current assets:97233990
Noncurrent Assets
Operating lease, right-of-use asset742
Property, plant and equipment511
Long-term investments and receivables 12 
Long-term investments 12 
Restricted cash and investments600
Other noncurrent assets1051
Total noncurrent assets:95202
TOTAL ASSETS:1,06735992
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities29115
Accounts payable931
Accrued liabilities2094
Debt 0 
Other undisclosed current liabilities2  
Total current liabilities:31125
Noncurrent Liabilities
Long-term debt and lease obligation752 
Operating lease, liability752
Liabilities, other than long-term debt001
Other liabilities001
Other undisclosed noncurrent liabilities100  
Total noncurrent liabilities:17521
Total liabilities:207145
Stockholders' equity
Stockholders' equity attributable to parent86134587
Common stock000
Additional paid in capital1,152503198
Accumulated other comprehensive income00 
Accumulated deficit(291)(158)(111)
Total stockholders' equity:86134587
TOTAL LIABILITIES AND EQUITY:1,06735992

Income statement (P&L) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
Operating expenses(136)(49)(26)
Operating loss:(136)(49)(26)
Nonoperating income (expense)32(4)
Investment income, nonoperating32 
Other nonoperating income (expense)00(4)
Interest and debt expense(0)(0)(11)
Loss from continuing operations before equity method investments, income taxes:(133)(47)(42)
Other undisclosed income from continuing operations before income taxes0 0
Loss from continuing operations before income taxes:(133)(47)(41)
Income tax expense(0)  
Net loss available to common stockholders, diluted:(133)(47)(41)

Comprehensive Income ($ in millions)

12/31/2020
12/31/2019
12/31/2018
Net loss:(133)(47)(41)
Comprehensive loss:(133)(47)(41)
Other undisclosed comprehensive income, net of tax, attributable to parent00 
Comprehensive loss, net of tax, attributable to parent:(133)(47)(41)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: